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Interest in the management of dilated cardiomyopathy hasrecently been enhanced by the development of bridge torecovery techniques that use mechanical circulatory sup-port.1-5 A previously reported program of this type, combin-
ing mechanical with pharmacologic support involving induction of
reverse remodeling followed by physiologic hypertrophy, has been
developed at Harefield Hospital.6 After recovery, explantation of
left ventricular assist devices has traditionally comprised median
sternotomy and laparotomy7,8 with the associated extensive dis-
section of adhesions that can increase morbidity and mortality. To
avoid these complications, we have developed and evaluated a new
minimally invasive approach.
Method
The apex of the heart is exposed through an anterolateral minitho-
racotomy (Figure 1). Two other separate small incisions are made:
an epigastric incision to expose the device and a limited anterior
thoracotomy through the second intercostal space to expose the
aortic anastomosis of the outflow cannula (Figure 2). Femorofemo-
ral cardiopulmonary bypass is established, and the heart is fibril-
lated electrically to allow explantation of the device inflow can-
nula. After deairing, which is easily accomplished by rotation of
the operating table to the right and partial constriction of the
venous return cannula, the apex is repaired by direct suture (Figure
3). The heart is then defibrillated electrically with external or small
internal paddles. Cardiopulmonary bypass is then discontinued,
with strict monitoring of pulmonary arterial pressure by means of
a thermodilution catheter (Swan-Ganz; Baxter Healthcare Corp,
Edwards Division, Santa Ana, Calif). The outflow graft is divided
as close as possible to the aortic anastomosis. The residual graft
stump, which measures 2 to 3 mm in length, is oversewn (Figure
4), and the device is then explanted, along with the intrathoracic
part of the Dacron polyester fabric graft, by traction applied from
below (Figure 5).
Results
During the past 18 months we have used this technique to explant
devices from 12 consecutive patients and have studied these cases
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Figure 1. Diagram showing sites of minimally invasive incisions
and arteriovenous cannulation in groin.
Figure 2. Diagram showing dissection of inflow cannula through
minimally invasive anterior thoracotomy. Cannula is then ex-
tracted during short period of cardiopulmonary bypass.
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Figure 3. Drive line is divided close to device and is removed by
traction from outside.
Figure 4. Body of device is explanted after dissection around diaphragmatic passage of inflow cannula. Outflow
cannula is exposed through anterior thoracotomy, then clamped and divided as close as possible to the ascending
aorta. Stump is oversewn. An inset to Figure 4 is shown on the right.
Figure 5. Finally, device is completely removed by traction on
outflow graft from below.
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on a prospective basis. All patients were supported by Thoratec
HeartMate devices (11 HeartMate I and 1 HeartMate II; Thoratec
Laboratories Corporation, Pleasanton, Calif, formerly Thermo
Cardiosystems Inc). One patient died early of unrelated causes,
and the 11 remaining patients all made a smooth recovery. Mean
(SD) intensive treatment unit stay was 6.2  3.3 days, with
no cases of cerebral dysfunction, thromboembolism, or organ
failure. Serious infection was not encountered. One patient had a
superficial epigastric wound infection, which was treated conser-
vatively.
Conclusion
We have evolved and used a simple, minimally invasive approach
that appears to be safe, with a low complication rate. Because of
increasing interest in bridge to recovery programs, we anticipate
that this technique may become increasingly useful in reducing
morbidity and mortality during the explantation of these devices.
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